Literature DB >> 25556420

Autologous graft-versus-host disease in a child with stage IV neuroblastoma.

Jessica Kaffenberger1, Sarah A Basak, Michael Ioffreda.   

Abstract

Graft-versus-host disease (GVHD) is an underappreciated complication of autologous hematopoietic stem cell transplantation (AHSCT) that can affect the skin, gastrointestinal tract, and liver. The development of this rare condition is probably due to an impairment of immunologic tolerance that can occur spontaneously through T-cell dysregulation, possibly from intensive conditioning chemotherapy regimens, or intentionally through administration of cyclosporine in the hopes of promoting an antitumor response. We present the case of a 2-year-old boy with metastatic neuroblastoma who spontaneously developed autologous GVHD after AHSCT. Severe pruritus and an inability to taper his oral steroids without a disease flare marked his disease. Eventually partial relief was achieved with initiation of cyclosporine and a strict soak and smear protocol using topical triamcinolone 0.1% ointment.
© 2014 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25556420     DOI: 10.1111/pde.12407

Source DB:  PubMed          Journal:  Pediatr Dermatol        ISSN: 0736-8046            Impact factor:   1.588


  3 in total

1.  Alloreactivity: the Janus-face of hematopoietic stem cell transplantation.

Authors:  A Gratwohl; A Sureda; J Cornelissen; J Apperley; P Dreger; R Duarte; H T Greinix; E Mc Grath; N Kroeger; F Lanza; A Nagler; J A Snowden; D Niederwieser; R Brand
Journal:  Leukemia       Date:  2017-03-08       Impact factor: 11.528

2.  Graft-versus-host disease in a child with neuroblastoma after autologous stem cell transplantation.

Authors:  Yöntem Yaman; Gökhan Baysoy; Emre Keleşoğlu; Kürşat Özdilli; Aslı Çakır; Dildar Bahar Genç; Murat Elli; Sema Anak
Journal:  Contemp Oncol (Pozn)       Date:  2019-03-25

3.  Cancer stem cells in neuroblastoma therapy resistance.

Authors:  Natarajan Aravindan; Drishti Jain; Dinesh Babu Somasundaram; Terence S Herman; Sheeja Aravindan
Journal:  Cancer Drug Resist       Date:  2019-11-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.